Eli Lilly and Company - Other Operating Expenses
Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Operating-Expenses" stands at -0.4617 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 12/31/2017.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.2307 Billion United States Dollars compared to the value the year prior.
The 1 year change is 0.2307 Billion United States Dollars.
The 3 year change is 0.925 Billion United States Dollars.
The 5 year change is 2.29 Billion United States Dollars.
The Serie's change in United States Dollars from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +5.21 Billion.
The Serie's change in United States Dollars from it's maximum value, on 03/31/2017, to it's latest available value, on 09/30/2025, is -0.4215 Billion.
Other Operating Expenses for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Johnson & Johnson - Other Operating Expenses | 486,508,953,600.00 |
 | AbbVie Inc - Other Operating Expenses | 399,570,305,024.00 |
 | Roche Holding AG - Other Operating Expenses | 317,433,206,677.55 |
 | AstraZeneca PLC - Other Operating Expenses | 280,205,508,085.11 |
 | Novartis AG - Other Operating Expenses | 255,096,620,580.91 |